Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Traxion Sab De Cv Ord Shs GRPOF

Grupo Traxion SAB de CV is a Mexico-based company engaged in the transportation sector. The Company provides logistics services within eight business areas: Fright, including intermodal and multimodal services, door-to-door, national and cross-border distribution, among others; Integrated logistics, including logistics management, aerial and maritime services and custom transportation support... see more

PINL:GRPOF - Post Discussion

Traxion Sab De Cv Ord Shs > Health Canada
View:
Post by Sweeetydi on Feb 09, 2019 4:25am

Health Canada

To anyone of the belief that Tetra weren’t testing their drug lots for the entirety of the trial, you need to read HCs policy on CTs.  Tetra wouldn’t have been given the green light to commence trials and continue if they weren’t. The tests weren’t positive for toxins until the test lot from 20 Dec 2018 returned. 

The positive from this unfortunate situation is that no patients received contaminated drugs and that phase 3 is completed/ won’t need to be repeated.

Alright, so there’s a delay.  We have an NDA application for 002 coming anyday. Perhaps that’s what TBP are anticipating.  The NR from Thursday certainly gets across that having one DIN can really increase valuation, so 002 will be our first.
Comment by Buster146 on Feb 09, 2019 11:12am
Thank you you contribute great material.   2019 is going to be a great year for us PERIOD!
Comment by new2mjstocks on Feb 09, 2019 11:20am
if the phase 3 does not have to be repeated why the 6 month delay? also, i thought 005 was more advanced and would come to commercialization quicker than 002 tia
Comment by Sweeetydi on Feb 09, 2019 11:32am
Reason for delay is to standardize drying/storage and ensure no risk of contamination.  002- prescription drug. 005- NHP.
Comment by cannatrader22 on Feb 11, 2019 10:41am
This post has been removed in accordance with Community Policy
Comment by cannatrader22 on Feb 16, 2019 7:52pm
This post has been removed in accordance with Community Policy
Comment by cannatrader22 on Feb 16, 2019 7:52pm
This post has been removed in accordance with Community Policy
Comment by cannatrader22 on Feb 16, 2019 7:52pm
This post has been removed in accordance with Community Policy
Comment by cannatrader22 on Feb 16, 2019 7:52pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities